Resources
Links to resources
Please contact us if you have any questions.
Public Health Agency HSC NI documents
UK Health Security Agency
Police Service Northern Ireland
Department of Health NI documents
- HSS MD 40 2024 letter- MHRA Drug ~ MedSafetyWeek November 2024 your Yellow Card report helps prevent future harm to others and improves patient safety
- HSS MD 39 2024 AUTUMN 2024 25 SEASONAL INFLUENZA AND COVID-19 VACCINATION PROGRAMMES FOR HEALTH AND SOCIAL CARE WORKERS
- Circular Providing Clarification Guidance on Roles and Responsibilities - Accessing Private Healthcare
- HSS(MD) 35 2024 - SEASONAL INFLUENZA VACCINATION PROGRAMME 2024 2025 - EXTENSION TO ALL HEALTH AND SOCIAL CARE WORKERS
- ADDENDUM HSS(MD) 34 2024 - COVID-19 AUTUMN 2024 BOOSTER VACCINATION PROGRAMME
- HSS MD 33 2024 SEASONAL INFLUENZA VACCINATION PROGRAMME 2024 2025
- HSS(MD) 24 2024 - INTRODUCTION OF UNIVERSAL RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINATION PROGRAMME FOR OLDER ADULTS AND DURING PREGNANCY FOR INFANT PROTECTION
- HSS(MD) 22 2024 - MEDICINE SUPPLY NOTIFICATION - PABRINEX® (VITAMINS B AND C) INTRAVENOUS AND INTRAMUSCULAR HIGH POTENCY SOLUTION FOR INJECTION AMPOULES
- HSS(MD) 21 2024 - MHRA DRUG SAFETY UPDATE – TOPIRAMATE (TOPAMAX) INTRODUCTION OF NEW SAFETY MEASURES, INCLUDING A PREGNANCY PREVENTION PROGRAMME
- HSSMD-20-2024-NEW-RESTRICTIONS-ON-USE-OF-PUBERTY-SUPPRESSING-HORMONES-PUBERTY-BLOCKERS-IN-GREAT-BRITAIN-–-INFORMATION-FOR-PRESCRIBERS-AND-PHARMACISTS-DISPENSING-DOCTORS
- ADDENDUM-TO-HSSMD-51-2023-FULL-PACK-DISPENSING-OF-VALPROATE-CONTAINING-MEDICINES
- HSSMD-19-2024-MHRA-Drug-Safety-Update-–-Topical-steroids-introduction-of-new-labelling-and-a-reminder-of-the-possibility-of-severe-side-effects-including-Topical-Steroid-Withdrawal-Reactions
- HSSMD-18-2024-NATIONAL-PATIENT-SAFETY-ALERT-SHORTAGE-OF-PANCREATIC-ENZYME-REPLACEMENT-THERAPY-PERT
- HSS-MD-15-2024-NATIONAL-PATIENT-SAFETY-ALERT-Shortage-of-Orencia-Clickject-125mg-1ml-solution-for-injection-pre-filled-pens
- HSS-MD-16-2024-HEPATITIS-C-TESTING-GUIDANCE
- TMSNI-Newsletter-LMcM-Letter-May-2024
- TMSNI-News-Issue1
- HSSMD-17-2024-END-OF-THE-2023-24-INFLUENZA-SEASON-AND-RELATED-ISSUES
- HSSMD-14-2024-MHRA-Drug-Safety-Update-Finasteride-and-Montelukast
- HSS-MD-12-2024-COVID-19-TREATMENTS-UPDATED-NICE-GUIDANCE-TA878-Nirmatrelvir-plus-ritonavir-sotrovimab-and-tocilizumab-for-treating-COVID-19
- HSSMD-10-2024-UPDATE-TO-COVID-19-TESTING-GUIDANCE-HSSMD-CIRCULARS-WITHDRAWN
- HSSMD-09-2024-NATIONAL-PATIENT-SAFETY-ALERT-–-SHORTAGE-OF-SALBUTAMOL-2.5MG-2.5ML-AND-5MG-2.5ML-NEBULISER-LIQUID-UNIT-DOSE-VIALS
- HSSMD-08-2024-MHRA-DRUG-SAFETY-UPDATE-–-PSEUDOEPHEDRINE-VERY-RARE-RISK-OF-POSTERIOR-REVERSIBLE-ENCEPHALOPATHY-SYNDROME-PRES-AND-REVERSIBLE-CEREBRAL-VASOCONSTRICTION-SYNDROME-RCVS
- HSSMD-07-2024-MHRA-DRUG-SAFETY-UPDATE-–-CODEINE-LINCTUS-CODEINE-ORAL-SOLUTIONS-RECLASSIFICATION-TO-PRESCRIPTION-ONLY-MEDICINE
- HSSMD-06-2024-VALPROATE-IMPORTANT-NEW-REGULATORY-MEASURE-FOR-OVERSIGHT-OF-PRESCRIBING-TO-NEW-PATIENTS-AND-EXISTING-FEMALE-PATIENTS
- HSS-MD-4-2024-Fluoroquinolone-antibiotics-and-Omega-3-acid-ethyl-ester-medicines
- CNO-Letter-to-Sector-Nursing-Officer-for-Older-People-Applications
- Nursing-Officer-for-Older-People-Secondment-Opportunity-Notice-March-2024
- HSS-MD-3-2024-MHRA-Drug-Safety-Update-–-Valproate-Belvo-Convulex-Depakote-Dyzantil-Epilim-Epilim-Chrono-or-Chronosphere-Episenta-Epival-and-Syonell
- HSSMD-02-2024-SEASONAL-INFLUENZA-VACCINATION-OFFER-TO-ALL-50-64-YEAR-OLDS-AND-ALL-HEALTH-AND-SOCIAL-CARE-WORKERS
- HSS-MD-55-2023-Addendum-MHRA-DRUG-SAFETY-UPDATE-ISOTRETINOIN-ROACCUTANE
Visit the Department of Health’s HSS(MD) Letters and urgent communications page
for more.